These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 2498657)

  • 1. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth.
    Cassady G; Crouse DT; Kirklin JW; Strange MJ; Joiner CH; Godoy G; Odrezin GT; Cutter GR; Kirklin JK; Pacifico AD
    N Engl J Med; 1989 Jun; 320(23):1511-6. PubMed ID: 2498657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants.
    Bandstra ES; Montalvo BM; Goldberg RN; Pacheco I; Ferrer PL; Flynn J; Gregorios JB; Bancalari E
    Pediatrics; 1988 Oct; 82(4):533-42. PubMed ID: 3174314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus.
    Fujii AM; Brown E; Mirochnick M; O'Brien S; Kaufman G
    J Perinatol; 2002; 22(7):535-40. PubMed ID: 12368968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early enteral feeding does not affect the incidence of necrotizing enterocolitis.
    Ostertag SG; LaGamma EF; Reisen CE; Ferrentino FL
    Pediatrics; 1986 Mar; 77(3):275-80. PubMed ID: 3081868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?
    Cordero L; Nankervis CA; Delooze D; Giannone PJ
    J Perinatol; 2007 Mar; 27(3):158-63. PubMed ID: 17251986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of indomethacin tocolysis on the postnatal response of the ductus arteriosus to indomethacin in extremely low birth weight infants.
    Cordero L; Nankervis CA; Gardner D; Giannone PJ
    J Perinatol; 2007 Jan; 27(1):22-7. PubMed ID: 17053778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of low oxygen saturation limits on the ductus arteriosus in extremely low birth weight infants.
    Noori S; Patel D; Friedlich P; Siassi B; Seri I; Ramanathan R
    J Perinatol; 2009 Aug; 29(8):553-7. PubMed ID: 19461594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of sterile water by gavage drip in the fluid management of extremely low birth weight infants.
    Stewart CD; Morris BH; Huseby V; Kennedy KA; Moya FR
    J Perinatol; 2009 Jan; 29(1):26-32. PubMed ID: 18754014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes.
    Valverde E; Pellicer A; Madero R; Elorza D; Quero J; Cabañas F
    Pediatrics; 2006 Jun; 117(6):e1213-22. PubMed ID: 16717120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.
    Fanaroff AA; Korones SB; Wright LL; Wright EC; Poland RL; Bauer CB; Tyson JE; Philips JB; Edwards W; Lucey JF
    N Engl J Med; 1994 Apr; 330(16):1107-13. PubMed ID: 8133853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants.
    Mahony L; Carnero V; Brett C; Heymann MA; Clyman RI
    N Engl J Med; 1982 Mar; 306(9):506-10. PubMed ID: 7035955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is it safer to intubate premature infants in the delivery room?
    Aly H; Massaro AN; Patel K; El-Mohandes AA
    Pediatrics; 2005 Jun; 115(6):1660-5. PubMed ID: 15930230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
    Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN
    N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of prolonged pharmacologic serum levels of vitamin E to incidence of sepsis and necrotizing enterocolitis in infants with birth weight 1,500 grams or less.
    Johnson L; Bowen FW; Abbasi S; Herrmann N; Weston M; Sacks L; Porat R; Stahl G; Peckham G; Delivoria-Papadopoulos M
    Pediatrics; 1985 Apr; 75(4):619-38. PubMed ID: 3885152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic closure of the ductus arteriosus: benefits and limitations.
    Mercanti I; Boubred F; Simeoni U
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there an optimal timing for surgical ligation of patent ductus arteriosus in preterm infants?
    Vida VL; Lago P; Salvatori S; Boccuzzo G; Padalino MA; Milanesi O; Speggiorin S; Stellin G
    Ann Thorac Surg; 2009 May; 87(5):1509-15; discussion 1515-6. PubMed ID: 19379895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier.
    Berseth CL; Van Aerde JE; Gross S; Stolz SI; Harris CL; Hansen JW
    Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased incidence of bronchopulmonary dysplasia after early management changes, including surfactant and nasal continuous positive airway pressure treatment at delivery, lowered oxygen saturation goals, and early amino acid administration: a historical cohort study.
    Geary C; Caskey M; Fonseca R; Malloy M
    Pediatrics; 2008 Jan; 121(1):89-96. PubMed ID: 18166561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.